12:00 AM
 | 
Jan 14, 2013
 |  BC Week In Review  |  Company News  |  Deals

Inviragen, The Company for Vaccine and Biological Production No. 1 deal

VABIOTECH received exclusive rights to develop and commercialize in Vietnam, Cambodia and Myanmar a Japanese encephalitis (JE) vaccine based on Inviragen's cell-based JE...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >